Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021
- 20 June 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 47 (8) , 668-679
Abstract
Designer benzodiazepine (DBZD) use has been increasing over the past decade and poses a threat to human health and safety, particularly when involved in driving under the influence of drug (DUID) cases. Over a 5-year period between 2017 and 2021, there were 1,145 reported DBZDs in 805 blood samples submitted from law enforcement agencies for DUID testing. Eleven different DBZDs were detected, including three metabolite pairs: etizolam/alpha-hydroxyetizolam, clonazolam/8-aminoclonazolam, diclazepam/delorazepam, flualprazolam, flubromazolam, flubromazepam, bromazolam and bromazepam. Etizolam/alpha-hydroxyetizolam (n = 485) and flualprazolam (n = 149) were the most frequently detected DBZDs, at 60% and 18%, respectively. Driving behavior, standardized field sobriety test performance and physical observations of individuals suspected of DUIDs, whose blood sample was toxicologically confirmed for one or more DBZDs, were consistent with the effects caused by central nervous system depressants. Each DBZD has its own unique timeline, and toxicology testing had to be frequently updated to reflect the state of the novel psychoactive substance market. DBZDs play a role in impaired driving and can be the sole intoxicant in DUID cases.Keywords
This publication has 41 references indexed in Scilit:
- Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014–2017Clinical Toxicology, 2018
- Occurrence and time course of NPS benzodiazepines in Sweden – results from intoxication cases in the STRIDA projectClinical Toxicology, 2018
- Assessment of the Availability, Cost, and Motivations for Use over Time of the New Psychoactive Substances—Benzodiazepines Diclazepam, Flubromazepam, and Pyrazolam—in the UKJournal of Medical Toxicology, 2018
- Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2017 UpdateJournal of Analytical Toxicology, 2017
- Blood concentrations of new designer benzodiazepines in forensic casesForensic Science International, 2016
- Metabolites replace the parent drug in the drug arena. The cases of fonazepam and nifoxipamForensic Toxicology, 2016
- ELISA Detection of Phenazepam, Etizolam, Pyrazolam, Flubromazepam, Diclazepam and Delorazepam in Blood Using Immunalysis®Benzodiazepine KitJournal of Analytical Toxicology, 2015
- Detection of Phenazepam in Impaired DrivingJournal of Analytical Toxicology, 2013
- Phenazepam and its Effects on DrivingJournal of Analytical Toxicology, 2012
- Toxicological investigations of drivers killed in road traffic accidents in Norway during 2006–2008Forensic Science International, 2011